FIROCOXIB tablet, chewable United States - English - NLM (National Library of Medicine)

firocoxib tablet, chewable

felix pharmaceuticals private limited - firocoxib (unii: y6v2w4s4wt) (firocoxib - unii:y6v2w4s4wt) - firocoxib chewable tablets are indicated for the control of pain and inflammation associated with osteoarthritis and for the control of postoperative pain and inflammation associated with soft-tissue and orthopedic surgery in dogs. dogs with known hypersensitivity to firocoxib should not receive firocoxib.

PRAZIQUANTEL tablet, chewable United States - English - NLM (National Library of Medicine)

praziquantel tablet, chewable

felix pharmaceuticals private limited - praziquantel (unii: 6490c9u457) (praziquantel - unii:6490c9u457) - praziquantel tablets 34 mg canine cestocide are indicated for the removal of the following canine cestodes: dipylidium caninum, taenia pisiformis, echinococcus granulosus and for the removal and control of echinococcus multilocularis.   there are no known contraindications to the use of praziquantel in dogs.

ENROFLOXACIN FLAVORED- enrofloxacin tablet United States - English - NLM (National Library of Medicine)

enrofloxacin flavored- enrofloxacin tablet

felix pharmaceuticals private limited - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin flavored tablets are indicated for the management of diseases associated with bacteria susceptible to enrofloxacin. enrofloxacin flavored tablets are indicated for use in dogs and cats. enrofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. dogs: based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months. in clinical field trials utilizing a daily oral dose of 5.0 mg/kg, there were no reports of lameness or joint problems in any breed. however, controlled studies with histological examination of the articular cartilage have not been conducted in the large or giant breeds.

MARBOFLOXACIN tablet, chewable United States - English - NLM (National Library of Medicine)

marbofloxacin tablet, chewable

felix pharmaceuticals private limited - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - marbofloxacin chewable tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.

MELOXICAM injection, solution United States - English - NLM (National Library of Medicine)

meloxicam injection, solution

felix pharmaceuticals private limited - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - dogs: meloxicam injection is indicated in dogs for the control of pain and inflammation associated with osteoarthritis. dogs with known hypersensitivity to meloxicam should not receive meloxicam injection. cats: for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration when administered prior to surgery. cats with known hypersensitivity to meloxicam should not receive meloxicam injection. additional doses of meloxicam or other nsaids in cats are contraindicated, as no safe dosage for repeated nsaid administration has been established (see animal safety). do not use meloxicam in cats with pre-existing renal dysfunction.

Enrocin Flavoured Tablets 15 mg United Kingdom - English - VMD (Veterinary Medicines Directorate)

enrocin flavoured tablets 15 mg

felix pharmaceuticals pvt limited - enrofloxacin - tablet - antimicrobial - cats, dogs

Enrocin Flavoured Tablets 50 mg United Kingdom - English - VMD (Veterinary Medicines Directorate)

enrocin flavoured tablets 50 mg

felix pharmaceuticals pvt limited - enrofloxacin, water purified - tablet - antimicrobial - dogs

Enrocin Flavoured Tablets 150 mg United Kingdom - English - VMD (Veterinary Medicines Directorate)

enrocin flavoured tablets 150 mg

felix pharmaceuticals pvt limited - enrofloxacin - tablet - antimicrobial - dogs

Lemicam 1 mg Chewable Tablets for Dogs United Kingdom - English - VMD (Veterinary Medicines Directorate)

lemicam 1 mg chewable tablets for dogs

felix pharmaceuticals pvt limited - meloxicam - chewable tablet - anti inflammatory nsaid - dogs

Lemicam 2.5 mg Chewable Tablets for Dogs United Kingdom - English - VMD (Veterinary Medicines Directorate)

lemicam 2.5 mg chewable tablets for dogs

felix pharmaceuticals pvt limited - meloxicam - chewable tablet - anti inflammatory nsaid - dogs